“Alternative Therapies: Anti-TNF (Infliximab, And Adalimumab) Agents And Radiological Response For Refractory Sarcoidosis”, Rev Diabet Stud, pp. 768–784, Sep. 2025, doi: 10.70082/bzt09243.